Business Micro
News Stories
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer
Business Wire India New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus…
Read MoreBrenus Pharma’s Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.
Business Wire India Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery…
Read MoreBhubaneswar Hosts 19th Urban Mobility India Conference With Focus on Digital, Inclusive Cities
Oct 24: Bhubaneswar is hosting the 19th Urban Mobility India (UMI) Conference and Expo on October 23–24, 2026, bringing together…
Read MoreIndia Eyes USD 220 Billion Clean Energy Investment by FY2030 as Renewable Sector Accelerates
New Delhi, Oct 24: India is poised to unlock an estimated $220 billion in clean energy investment opportunities between FY2027…
Read MoreSiwan Blast: Fire in Firecracker Stock Triggered Deadly Chain of Explosions
Bihar, Oct 24: A massive explosion at a house in Alampur village, Bihar’s Siwan district, was triggered after firecrackers stored…
Read MoreInfosys:Differentiated AI strategy and a sharp focus on value unlock propels 29% sequential growth in AI revenues
Robust Q2 large deal TCV at $5.2 billion with 62% net new; lays solid foundation for future growth FY 27…
Read MorePhilip Morris International Reports 2026 Third-Quarter & First Nine-Months Results and Updates 2026 Full-Year Adjusted Diluted EPS Forecast for Currency Only
Third-Quarter Reported Diluted EPS declined by 4.9% to $2.12;Adjusted Diluted EPS grew by 5.4% to $2.36; and by 5.8% excluding…
Read MoreTCL Zhonghuan Powers India’s Energy Transition with PV Innovations at REI Expo 2026
GREATER NOIDA, India, Oct. 23, 2026 /PRNewswire/ — The Renewable Energy India Expo (REI) opened on October 22 at the…
Read MoreTakeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study
Business Wire India Data from the Registrational Phase 3 G-HOPE-001 Study of Arcotatug Tavatecan, a Novel, Potential Best-in-Class Claudin (CLDN)18.2…
Read MoreSLB Announces Third-Quarter 2026 Results
Business Wire India Revenue of $9.45 billion increased 5% sequentially and 6% year on year GAAP EPS of $0.49 decreased…
Read More